INTELEOS features comprehensive data on drugs, biologics and biosimilars to help you get intelligence on new partners and competitors; study outcomes to inform your business; and monitor development trends.
Your INTELEOS subscription will include:Advisory Committee One:
Fully Searchable Orange Book Patent Information:
Beat Your Competitors to be the First Generic on the MarketPHASE PROGRESSION CHART
Illustrates the progression of drugs through clinical development on a quarterly basis.Easy and intuitive searching gives you the flexibility to combine search fields, terms and filters for the best results. You can select filters and "add" with the relevant Boolean operator to 'My Query."
Interactive tools allow graphical and numerical analysis for "Drugs" and "Clinical Trials." Each tool analyzes the data from a different perspective to meet the needs of our users and can be exported as graphics or reports. The "Comparison Analysis" provides a head-to-head comparison of the data by simply selecting the fields you wish to compare and group the data using the drop-down box.
Search and view the phase and status of the trial and see interventions, conditions and sponsors. For complete trial details, click on study name and link directly to ClinicalTrials.gov.
"Advisory Committee One" is your single source for committee member and drug review histories, meeting participants, committee members' backgrounds, meeting objectives and roster, and voting tallies and final recommendations.
Beat your competitors to be the first generic on the market. Obtain patent expiration and exclusivity dates, related applications and patent classifications for FDA-approved drugs.